Biosciences

Acquisition expands Castle’s estimated U.S. TAM by approximately $5.0 billion to $8.0 billion Castle also announces expanded Medicare coverage…

Furthers mid- and long-term growth with strategic advance into pharmacogenomics and mental health Castle executive management to host…

Acquisition to accelerate scaling of BigHat’s AI/ML-enabled drug discovery platform BigHat Biosciences, Inc., a biotechnology company developing…

Company Will Explore How its Microbial-Based Technologies Can Be Used to Create Policies That Reduce Risks, Lower Premiums and Expand Protection…

Persephone Biosciences Inc., a biotechnology company aiming to develop better treatment outcomes and improve disease prevention through a greater…

Bio-Techne's proven and established RNAScope® technology combined with Akoya's powerful new PhenoCycler™-Fusion system will enable comprehensive…

Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion…

Quantum Numbers Corp. is pleased to announce the appointment of Mr. Francis Bellido as Chief Executive Officer (“CEO”). With its latest successful…

Gestalt Diagnostics and Flagship Biosciences announced their collaboration in the development of an integrated workflow for pathologists to access…